drugset / Trial / NCT01160120

Therapeutic Drug Monitoring (TDM) in Generic Tenofovir/Lamivudine/Efavirenz

NCT01160120 ↗

NaSingle-groupOpen-labelOther

Summary

The purpose of this study is to determine the mid levels of the tenofovir, lamivudine, and efavirenz, and 144 weeks safety and efficacy of the generic fixed dose combination of tenofovir /lamivudine/efavirenz tablets 300/300/600 mg in Thai HIV-infected patients.

Timeline

Start
2010-06
Primary completion
2013-05
Completion
2015-06

Publications

  • Results Avihingsanon A, Sophonphan J, Thammajaruk N, Chaihong P, Burger D, Cressey TR, Ramautarsing RA, Praditornsilpa K, Avihingsanon Y, Ruxrungtham K and HIV-NAT 114 study team. Plasma Tenofovir Concentrations and Proximal Tubular Dysfunction in HIV-Infected Adults Receiving Tenofovir in Thailand. AIDS Clin Res 2015, 6:7 Doi: http://dx.doi.org/10.4172/2155-6113.1000477

Drugs

EvaluationDrugModalityDoseRoute
Subject TDF/3TC/EFV Unknown 300 mg Oral
Subject TDF/3TC/EFV Unknown 600 mg Oral